| The genomic landscape of pediatric acute lymphoblastic leukemia SW Brady, KG Roberts, Z Gu, L Shi, S Pounds, D Pei, C Cheng, Y Dai, ... Nature genetics 54 (9), 1376-1389, 2022 | 149 | 2022 |
| Protein Ontology (PRO): enhancing and scaling up the representation of protein entities DA Natale, CN Arighi, JA Blake, J Bona, C Chen, SC Chen, KR Christie, ... Nucleic acids research 45 (D1), D339-D346, 2017 | 94 | 2017 |
| A six-gene leukemic stem cell score identifies high risk pediatric acute myeloid leukemia AH Elsayed, R Rafiee, X Cao, S Raimondi, JR Downing, R Ribeiro, Y Fan, ... Leukemia 34 (3), 735-745, 2020 | 64 | 2020 |
| Polygenic Ara-C response score identifies pediatric patients with acute myeloid leukemia in need of chemotherapy augmentation AH Elsayed, X Cao, AK Mitra, H Wu, S Raimondi, C Cogle, Z Al-Mansour, ... Journal of Clinical Oncology 40 (7), 772, 2022 | 14 | 2022 |
| The genomic landscape of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 Q Gao, SL Ryan, I Iacobucci, PS Ghate, RE Cranston, C Schwab, ... Blood 142 (8), 711-723, 2023 | 11 | 2023 |
| A ten-gene DNA-damage response pathway gene expression signature predicts gemtuzumab ozogamicin response in pediatric AML patients treated on COGAAML0531 and AAML03P1 trials MO Gbadamosi, VM Shastri, AH Elsayed, R Ries, O Olabige, ... Leukemia 36 (8), 2022-2031, 2022 | 9 | 2022 |
| Comprehensive Ara-C SNP score predicts leukemic cell intracellular ara-CTP levels in pediatric acute myeloid leukemia patients AH Elsayed, X Cao, KR Crews, V Gandhi, W Plunkett, JE Rubnitz, ... Pharmacogenomics 19 (14), 1101-1110, 2018 | 9 | 2018 |
| Genome-wide CRISPR/Cas9 screen identifies etoposide response modulators associated with clinical outcomes in pediatric AML NHK Nguyen, R Rafiee, A Tagmount, A Sobh, A Loguinov, ... Blood Advances 7 (9), 1769-1783, 2023 | 7 | 2023 |
| Comprehensive genome characterization of childhood T-ALL links oncogene activation mechanism and subtypes to prognosis P Pölönen, A Elsayed, D Di Giacomo, L Montefiori, S Kimura, J Myers, ... Blood 140 (Supplement 1), 1727-1729, 2022 | 7 | 2022 |
| SAMHD1 single nucleotide polymorphisms impact outcome in children with newly diagnosed acute myeloid leukemia RJ Marrero, X Cao, H Wu, AH Elsayed, JM Klco, RC Ribeiro, JE Rubnitz, ... Blood advances 7 (11), 2538-2550, 2023 | 6 | 2023 |
| Genome-scale CRISPR-Cas9 synthetic lethal screening of AML cell line identified functional modulators of etoposide resistance predictive of clinical outcome in AML patients R Rafiee, A Sobh, AH Elsayed, A Tagmount, CD Vulpe, JK Lamba Blood 134, 2685, 2019 | 5 | 2019 |
| MicroRNAs mediated regulation of expression of nucleoside analog pathway genes in acute myeloid leukemia NS Bhise, AH Elsayed, X Cao, S Pounds, JK Lamba Genes 10 (4), 319, 2019 | 5 | 2019 |
| S102: COMPREHENSIVE GENOME CHARACTERIZATION REVEALS NEW SUBTYPES AND MECHANISMS OF ONCOGENE DEREGULATION IN CHILDHOOD T-ALL P Pölönen, A Elsayed, L Montefiori, S Kimura, J Myers, D Hedges, J Xu, ... HemaSphere 6, 3-4, 2022 | 4 | 2022 |
| Polygenic pharmacogenomic markers as predictors of toxicity phenotypes in the treatment of acute lymphoblastic leukemia: a single-center study T Larkin, R Kashif, AH Elsayed, B Greer, K Mangrola, R Rafiee, N Nguyen, ... JCO Precision Oncology 7, e2200580, 2023 | 3 | 2023 |
| Impact of laparoscopic sleeve gastrectomy on cardiovascular pharmacotherapy in left ventricular assist device patients MA Al-Ani, MR Murray, MB Taha, L Meece, AH Elsayed, EI Jeng, ... Journal of Cardiovascular Pharmacology 79 (5), 646-649, 2022 | 2 | 2022 |
| Integrated genome wide association study (GWAS) identifies SNPs associated with outcome in pediatric AML AH Elsayed, H Wu, X Cao, S Meshinchi, R Ribeiro, J Rubnitz, S Pounds, ... Blood 132, 2758, 2018 | 2 | 2018 |
| Statistical Methods Inspired by Challenges in Pediatric Cancer Multi-omics X Cao, AH Elsayed, SB Pounds Statistical Genomics, 349-373, 2023 | 1 | 2023 |
| Progenitor sub-populations in treatment resistant T-ALL J Xu, C Chen, TL Vincent, P Pölönen, A Elsayed, J Hu, S Yoshimura, ... Blood 140 (Supplement 1), 1724-1726, 2022 | 1 | 2022 |
| A Transcriptional Classifier Identifies Pediatric T-Cell Acute Lymphoblastic Leukemias at High Risk for End of Induction Minimal Residual Disease LK Meyer, RP Roy, P Pölönen, A Elsayed, BJ Huang, S Kimura, ... Blood 140 (Supplement 1), 1722-1723, 2022 | 1 | 2022 |
| Predictors of survival to hospital discharge with IABP use in acute myocardial infarction with cardiogenic shock M Dimza, M Al-Ani, D Naik, S Kennedy, AH Elsayed, A Parker, M Ahmed, ... The Journal of Heart and Lung Transplantation 40 (4), S192, 2021 | 1 | 2021 |
